Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|November 3, 2021
Integrative Medicine Can Be Combined With Oncology Treatment for Neuroendocrine Tumors
Kaushal Nanavati, MD, assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center, discusses how integrative medicine can help treatment of neuroendocrine tumors in combination with other treatments.
Advertisement
In a Pharmacy Times® interview, Kaushal Nanavati, MD, FAAFP, ABOIM, ABIHM assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center, spoke about his 2021 NANETS presentation on the integrative management of neuroendocrine tumors (NETs).
He discussed how integrative medicine can help treatment of NETs in combination with other treatments.
Advertisement
Related to this article
A prospective observational study found microplastics more frequently and at higher levels in lung samples from patients with lung malignancies, although the findings do not establish that the particles cause cancer.
At the 2026 New England Institute of Ambulatory Care Pharmacists (NEIAP) Annual Forum, Jennifer Goldman detailed how monitoring data drive engagement—and how a new dual sensor readies pharmacists for ketone alerts.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Ataxia-telangiectasia (A-T) is a rare neurodegenerative disorder that primarily affects the nervous system, causing progressive loss of muscle control and coordination.
Most patients screened by a hospital pharmacist-led transitions-of-care service had unmet pneumococcal and other vaccine needs, and most accepted vaccination when offered.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
4
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
5